4th Quarter - Report

WATKINS & EAGER PLLC for ZYNERBA PHARMACEUTICALS, INC.

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Government Issues GOV

Brief key House & Senate Members and/or appropriate staff on need and justification for this product. Secure letter of support for applications from key House & Senate Members.

LobbyistCovered position, as disclosed
GREGG L HARPER Former Member of U.S. House of Representatives

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Assist in the development & approval process before the FDA of Zynerba's lead therapeutic for the potential treatment of behavioral symptoms associated with Fragile X Syndrome.

LobbyistCovered position, as disclosed
GREGG L HARPER Former Member of U.S. House of Representatives

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Pharmacy PHA

Support Zynerba and its partners, and any other of its contractors in its process before the FDA; Troubleshoot inevitable issues and eligibility hurdles to ensure the project is considered for approval; Brief staff of FDA throughout process to ensure they have all information needed; Work with Zynerba to formulate the best strategy to work with FDA in preparation for any scheduled meetings.

LobbyistCovered position, as disclosed
GREGG L HARPER Former Member of U.S. House of Representatives

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.